Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD19 CAR-T Combined With CD19+ Feeding T Cells for Consolidation Treatment for Acute Lymphoblastic Leukemia
NCT03984968Phase 2Active, not recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jul 2017
- Primary completion
- Jul 2025
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ssCART-19 in acute lymphoblastic leukemia (ALL), sponsored by First Affiliated Hospital of Soochow University. Started Jul 2017; status: active, not recruiting.
02
Drugs
ssCART-19
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT03984968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03984968.